XSESH02
Market cap1.79bUSD
Dec 20, Last price
10.98SGD
1D
-1.08%
1Q
0.64%
Jan 2017
20.79%
Name
Haw Par Corporation Ltd
Chart & Performance
Profile
Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, ASEAN countries, other Asian countries, and internationally. The company operates through three segments: Healthcare, Investments, and Others. The Healthcare segment principally manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brand. Its Investments segment invests primarily in quoted securities. In addition, the company owns and leases various investment properties that have lettable area of 45,324 square meters of commercial and industrial space in Singapore and Malaysia. Further, the company provides family and tourist oriented leisure alternatives principally in the form of oceanariums. Haw Par Corporation Limited leases land, building, and office space, as well as offers management support services. The company was incorporated in 1969 and is based in Singapore.
Valuation
Title SGD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 232,062 27.44% | 182,092 28.98% | 141,180 27.15% | |||||||
Cost of revenue | 168,051 | 138,713 | 116,483 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 64,011 | 43,379 | 24,697 | |||||||
NOPBT Margin | 27.58% | 23.82% | 17.49% | |||||||
Operating Taxes | 12,825 | 10,653 | 6,077 | |||||||
Tax Rate | 20.04% | 24.56% | 24.61% | |||||||
NOPAT | 51,186 | 32,726 | 18,620 | |||||||
Net income | 216,569 46.02% | 148,316 34.71% | 110,103 -8.07% | |||||||
Dividends | (77,479) | (66,410) | (66,377) | |||||||
Dividend yield | 3.59% | 3.13% | 2.64% | |||||||
Proceeds from repurchase of equity | 179 | 175 | ||||||||
BB yield | -0.01% | -0.01% | ||||||||
Debt | ||||||||||
Debt current | 28,484 | 29,200 | 762 | |||||||
Long-term debt | 1,276 | 29,899 | 1,524 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | (638) | (29,200) | (762) | |||||||
Net debt | (3,199,142) | (3,430,012) | (3,134,965) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 62,684 | 40,942 | 18,841 | |||||||
CAPEX | (7,768) | (19,734) | (4,383) | |||||||
Cash from investing activities | 258,005 | (261,583) | 87,516 | |||||||
Cash from financing activities | (79,303) | (38,066) | (65,115) | |||||||
FCF | 102,050 | 17,327 | 20,504 | |||||||
Balance | ||||||||||
Cash | 3,210,021 | 334,268 | 596,226 | |||||||
Long term investments | 18,881 | 3,154,843 | 2,541,025 | |||||||
Excess cash | 3,217,299 | 3,480,006 | 3,130,192 | |||||||
Stockholders' equity | 3,476,003 | 3,551,447 | 3,213,983 | |||||||
Invested Capital | 287,188 | 90,453 | 76,522 | |||||||
ROIC | 27.11% | 39.20% | 25.80% | |||||||
ROCE | 1.83% | 1.21% | 0.77% | |||||||
EV | ||||||||||
Common stock shares outstanding | 221,368 | 221,368 | 221,293 | |||||||
Price | 9.75 1.77% | 9.58 -15.59% | 11.35 5.00% | |||||||
Market cap | 2,158,338 1.77% | 2,120,705 -15.57% | 2,511,676 5.05% | |||||||
EV | (1,040,804) | (1,309,307) | (623,289) | |||||||
EBITDA | 70,059 | 49,063 | 31,160 | |||||||
EV/EBITDA | ||||||||||
Interest | 1,555 | 525 | 27 | |||||||
Interest/NOPBT | 2.43% | 1.21% | 0.11% |